The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
RNA-seq and KRAS mutational status in ascitic pancreatic cancer cells: Novel results and distinct subsets.
Talia Golan
No relevant relationships to disclose
S. Gail Eckhardt
No relevant relationships to disclose
Chani Stossel
No relevant relationships to disclose
Dikla Atias
No relevant relationships to disclose
Guoliang Wang
No relevant relationships to disclose
Todd M. Pitts
No relevant relationships to disclose
Dara Aisner
Consultant or Advisory Role - Boehringer Ingelheim
Honoraria - Abbott Molecular; Illumina
Colin D. Weekes
No relevant relationships to disclose
Raanan Berger
No relevant relationships to disclose
Aik-Choon Tan
No relevant relationships to disclose